PicoWay incorporates the highest peak power and the shortest pulse durations of any aesthetic laser in the market. The combination of these two technological breakthroughs creates the strongest photo-mechanical impact, which enables the most safe and effective fracturing of tattoo ink or pigmentation. The revolutionary PicoWay technology is integrated into a proven, reliable Candela™ platform which ensures superior performance and low cost of ownership.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/72762556-syneron-launch-picoway-picosecond/
Exact Sciences Corp. (NASDAQ: EXAS) announced today that the U.S. Food and Drug Administration (FDA) has approved Cologuard, the company’s noninvasive, stool DNA colorectal cancer screening test. Cologuard is the first noninvasive screening test for colorectal cancer that analyzes both stool DNA and blood biomarkers and has been proven to find 92 percent of cancers and 69 percent of the most advanced precancerous polyps in average risk patients. Cologuard, which is available through healthcare providers, offers people 50 and older at average risk for colorectal cancer an easy–to–use screening test they can do in the privacy of their own home.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7092251-fda-approve-s-exact-sciences-cologuard-screening-test-colorectal-cancer/
Inspire Medical Systems, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved Inspire Upper Airway Stimulation (UAS) therapy for use in a subset of patients with moderate to severe Obstructive Sleep Apnea (OSA) who are unable to use Continuous Positive Airway Pressure (CPAP). Inspire therapy is a fully implanted neurostimulation device, the first of its kind for sleep apnea, that provides an alternative treatment that is proven, convenient and easy to use.
To view the Multimedia News Release, go to: http://www.multivu.com/mnr/7169651-fda-approves-inspire-upper-airway-stimulation-therapy-sleep-apnea
Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, announced the U.S. Food and Drug Administration (FDA) approval and launch of the Cochlear™ Nucleus® Hybrid Implant System, a revolutionary new hybrid hearing solution that helps people who may hear a little but are still missing a lot, even with their hearing aids. The Nucleus Hybrid System is a unique combination of proven solutions, which allows people to get back what they've been missing by amplifying the low-pitched hearing a person does have while restoring access to the high-pitched hearing they've lost. People who are candidates for the technology no longer have to worry about straining to hear with their hearing aids as the Nucleus Hybrid System will allow them to maximize their hearing in all frequencies.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/7150651-cochlear-fda-approval-u-s-launch-cochlear-nucleus-hybrid-implant-system
Back App proven to improve back pain and prevent office workers from falling victim to Sitting Disease, is a chair that is very different from all others.
Back pain is a modern epidemic, with recent high profile victims including UK Prime Minister David Cameron, model Jodie Kidd and tennis ace Andy Murray.
With 80% of people experiencing some form of back pain in their lifetime and the rise of tablet computers creating a generation hunched over screens - dubbed the ‘iPosture’ generation – the Back App is more relevant than ever in the effort to combat Sitting Disease which, in addition to back pain, has been linked to cardiovascular illness and cancer.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/51361-back-app-guarantee-improved-back-pain
Accelrys, Inc. (NASDAQ: ACCL), a leading provider of scientific innovation lifecycle management solutions, today announced that it has acquired Ireland-based QUMAS, a leading global provider of Cloud-based and on-premises enterprise compliance software supporting regulatory and quality operations in life sciences and other highly regulated industries. The QUMAS acquisition further extends Accelrys’ informatics portfolio with the addition of mission-critical, end-to-end document and process management compliance solutions. Proven quality management solutions supported by robust content and business process management capabilities provided by QUMAS advance Accelrys’ ability to help customers better manage the scientific innovation lifecycle by reducing regulatory risks, lowering quality costs, improving compliance effectiveness and increasing operational efficiency in bringing new products to market.
To view Multimedia News Release, go to http://www.multivu.com/mnr/62188-accelrys-acquires-compliance-and-quality-management-leader-qumas
UBM Tech makes its biggest move yet towards reinventing technology media with the announcement of a new community-driven InformationWeek. Combining the brand’s world renowned content, over 200 new expert contributors, fresh content-sharing tools, and a proven, editorially-facilitated engagement platform, the iconic 34-year old media brand is unlocking the ability for its community members – senior IT professionals – to digitally connect around the most pressing market issues they face. Users will be able to freely share ideas, gather peer feedback, and ultimately help shape the future of the technology market. Start engaging at InformationWeek.com.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/64283-informationweek
Are balding babies a growing epidemic? Toppik challenges the online world to this question in their new video, “Are Babies Going Bald?”
The answer, of course, is no, but by masquerading hair loss on the cutest of subjects, the one minute video campaign demonstrates the efficacy of the favorite cult solution, Toppik Hair Building Fibers, for filling in the finest of fine hair in an undetectable and instant way. Baby hair is notoriously thin with sporadic growth patterns, making it the perfect base for natural Toppik to showcase its proven, inconspicuous results in the series of before and after footage.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/63124-toppik-video-are-babies-going-bald
PLAYSTUDIOS today announced the global release of myVEGAS Slots for iOS and Android – the first mobile game offering real-world rewards to players. This move brings the proven success of PLAYSTUDIOS’ social casino gaming model from the web to mobile devices. More than 100,000 players have already redeemed over $10 million worth of real-world rewards as part of the program offering on the web. PLAYSTUDIOS expects to increase its market reach by 200 percent with the launch of myVEGAS Slots for mobile devices. myVEGAS also added four new Rewards Program partners to the roster, including Cirque du Soleil, House of Blues, Sugar Factory and the Las Vegas Monorail Company.
To view Multimedia News Release, go to http://www.multivu.com/mnr/64309-playstudios-launches-myvegas-slots-ios-android-facebook-app-goes-mobile
Cambium Networks™, a global leading provider of wireless broadband solutions, today launched PTP 650, a new sub-6 GHz addition to its field-proven PTP portfolio. The new product's flexibility, high capacity, reliability and security are ideally suited for wireless backhaul applications for public safety, government, utilities, oil and gas and service provider markets.
Cambium Networks™, a global leading provider of wireless broadband solutions, today launched ePMP, a revolutionary wireless access platform for connecting underserved and unconnected global communities. Built on a legacy of field-proven reliability, ePMP is the gold standard for powerful and secure yet affordable wireless broadband communications.
To view Multimedia News Release, go to http://www.multivu.com/mnr/63765-cambium-networks-wireless-broadband-solution-epmp-wireless-access-platform
